- Home
- GRI vs AGMH Comparison
GRI vs AGMH Comparison
Compare GRI & AGMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRI
- AGMH
- Stock Information
- Founded
- GRI 2018
- AGMH 2015
- Country
- GRI United States
- AGMH Hong Kong
- Employees
- GRI N/A
- AGMH N/A
- Industry
- GRI Biotechnology: Pharmaceutical Preparations
- AGMH EDP Services
- Sector
- GRI Health Care
- AGMH Technology
- Exchange
- GRI Nasdaq
- AGMH Nasdaq
- Market Cap
- GRI 3.2M
- AGMH 3.5M
- IPO Year
- GRI N/A
- AGMH 2018
- Fundamental
- Price
- GRI $1.35
- AGMH $2.38
- Analyst Decision
- GRI Strong Buy
- AGMH
- Analyst Count
- GRI 2
- AGMH 0
- Target Price
- GRI $22.00
- AGMH N/A
- AVG Volume (30 Days)
- GRI 110.6K
- AGMH 818.2K
- Earning Date
- GRI 08-13-2025
- AGMH 07-11-2025
- Dividend Yield
- GRI N/A
- AGMH N/A
- EPS Growth
- GRI N/A
- AGMH N/A
- EPS
- GRI N/A
- AGMH 6.43
- Revenue
- GRI N/A
- AGMH $32,044,575.00
- Revenue This Year
- GRI N/A
- AGMH N/A
- Revenue Next Year
- GRI N/A
- AGMH N/A
- P/E Ratio
- GRI N/A
- AGMH $0.33
- Revenue Growth
- GRI N/A
- AGMH N/A
- 52 Week Low
- GRI $1.10
- AGMH $1.09
- 52 Week High
- GRI $43.69
- AGMH $109.50
- Technical
- Relative Strength Index (RSI)
- GRI 41.49
- AGMH 41.92
- Support Level
- GRI $1.20
- AGMH $2.16
- Resistance Level
- GRI $1.35
- AGMH $2.59
- Average True Range (ATR)
- GRI 0.10
- AGMH 0.33
- MACD
- GRI 0.02
- AGMH 0.03
- Stochastic Oscillator
- GRI 37.60
- AGMH 51.05
About GRI GRI Bio Inc.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
About AGMH AGM Group Holdings Inc.
AGM Group Holdings Inc is an investment holding company. The company focuses on blockchain-oriented ASIC chip design; high-end crypto miner production and fintech technology software service. It generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.